This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: LLL, MAR, NFLX, JNPR, EOG

Stericycle (SRCL - Get Report) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. $94.50 price target. Company offers growth at an attractive price.

Tractor Supply (TSCO - Get Report) upgraded at Goldman from Sell to Neutral, Goldman Sachs said. Margin growth should begin to accelerate. $72 price target.

STOCK COMMENTS / EPS CHANGES

Alcoa (AA) estimates, target reduced at JP Morgan. AA estimates were cut through 2012, JP Morgan said. Aluminum prices remain weak and the company continues to face higher costs. Overweight rating and new $13 price target.

Alcoa numbers adjusted at UBS. Shares of AA now seen reaching $10.25, according to UBS. Estimates lowered on lower LME prices and ongoing European weakness. Neutral rating.

Acuity Brands (AYI) numbers increased at JMP. AYI estimates were raised through 2012, JMP Securities said. Higher pricing should drive margin expansion. Outperform rating and new $64 price target.

Acuity Brands numbers raised at Jefferies. Shares of AYI now seen reaching AYI, Jefferies said. Estimates also raised on solid first quarter results. Hold rating.

Celgene (CELG) target raised at Citigroup. CELG price target increased to $80, according to Citigroup. Company released positive guidance. Buy rating.

Celgene numbers raised at Jefferies. Shares of CELG now seen reaching $78, Jefferies said. Estimates also raised on bullish 2012 guidance. Buy rating.

Capital One (COF) added to Top Pick List at FBR. COF was placed on the Top Pick list, FBR Capital Markets said. Recent acquisitions should boost future earnings.

Cirrus Logic (CRUS) estimates raised at Oppenheimer through 2012, Oppenheimer said. Positive guidance update. Perform rating.

CVS Caremark (CVS) numbers raised at Credit Suisse. Shares of CVS now seen reaching $48, according to Credit Suisse. Estimates also increased, as the company has several potential earnings tailwinds. Outperform rating.

Juniper (JNPR - Get Report) estimates lowered at Oppenheimer through 2012, Oppenheimer said. Disappointing negative pre-announcement. Perform rating.

Juniper estimates, target lowered at Goldman. JNPR estimates were cut through 2013, Goldman Sachs said. Carriers are spending less and the company appears to be losing market share in the router business. Neutral rating and new $19 price target.

Juniper Networks estimates lowered at UBS. JNPR estimates lowered through 2012, UBS said. Weaker than expected preliminary 4Q results. Neutral rating.

Juniper estimates lowered at Jefferies. JNPR estimates lowered through 2012, Jefferies said. Negative pre-announcement. Buy rating.

Southwest (LUV) estimates lowered at UBS. LUV estimates lowered through 2012 on December revenue, UBS said. Maintain $9.50 price target and Neutral rating.

Macy's (M) estimates, target boosted at Credit Suisse. Shares of M now seen reaching $36, according to Credit Suisse. Estimates also upped, given strong sales momentum. Outperform rating.

Regeneron Pharmaceuticals (REGN) price target raised at Citigroup. REGN price target increased to $68 on strong initial Eylea sales, Citigroup said. Neutral rating.

Schnitzer Steel (SCHN) numbers cut at Goldman. Shares of SCHN now seen reaching $47, according to Goldman Sachs. Estimates also reduced, given margin compression. Neutral rating.

>To submit a news tip, email: tips@thestreet.com.

RELATED STORIES:






Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of RealMoney.com.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
BRO $32.58 -0.20%
EOG $89.10 -0.06%
H $57.73 -0.89%
JNPR $27.88 1.20%
MAR $78.01 -1.30%

Markets

DOW 18,054.25 -71.87 -0.40%
S&P 500 2,113.55 -7.24 -0.34%
NASDAQ 5,089.47 -8.5060 -0.17%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs